EVERSANA Merges with Waltz Health

August 26, 2025

EVERSANA announced a merger with Waltz Health to combine EVERSANA’s end-to-end pharmaceutical commercialization services with Waltz’s AI-driven prescription routing and payer-facing marketplace technology. Mark Thierer, co-founder and CEO of Waltz Health, will serve as CEO of the combined organization as the companies integrate capabilities to improve drug affordability, payer connectivity and patient access for specialty and high-cost therapies.

Buyers
EVERSANA
Targets
Waltz Health
Location
Illinois, United States
Transaction Type
Buyout

Explore More

Related Acquisitions

Build a buyer list for your deal

Find active buyers from recent acquisition patterns and move straight into outreach.